Locus Cell Co

Locus Cell Co Interest Expense

The Interest Expense of Locus Cell Co (6891.TWO) as of Oct 17, 2026 is 45.02 M TWD. In the previous year, Interest Expense was 41.38 M TWD — a change of 8.80% (higher).

Interest Expense

45.02 MTWD

YoY

8.80%

Last updated:

Interest Expense of Locus Cell Co is 2024 45.02 M TWD. Interest Expense of Locus Cell Co was 2023 41.38 M TWD. It decreases by 8.80% higher compared to the previous year.

The Locus Cell Co Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2021
-996,000.00 TWD
Jan 1, 2022
37.93 M TWD
Jan 1, 2023
41.38 M TWD
Jan 1, 2024
45.02 M TWD
The Locus Cell Co Interest Expense history
YEARInterest ExpenseYoY
45.02 MTWD+8.80%
41.38 MTWD+9.11%
37.93 MTWD-3,907.73%
-996,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Locus Cell Co Stock analysis

What does Locus Cell Co do? Locus Cell Co Ltd is a company based in Taipei, Taiwan, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company has 32 employees and went public on April 28, 2022. Its primary business involves the entrusted development and manufacturing of cell therapy-related products. Locus Cell Co Ltd utilizes a pilot facility compliant with Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) good manufacturing practices (GMP). The company provides services including process development and scale-up for cell therapy products, analytical method development and validation, clinical GMP manufacturing for trials, and stability testing. It is anticipated to offer services for various cell therapy applications, such as tissue engineering, CAR-T, induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs). The company's website is http://www.locus-cell.com/. Locus Cell Co Ltd focuses on contract development and manufacturing organization (CDMO) services for cell therapy products, aiming to support the advancement of innovative therapies through its specialized GMP-compliant facility and technical expertise in cell therapy processes. Locus Cell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Locus Cell Co stock

Interest Expense of Locus Cell Co is 45.02 M TWD in 2024.

Interest Expense of Locus Cell Co changed from 41.38 M TWD to 45.02 M TWD, representing a 8.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Locus Cell Co since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Locus Cell Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Locus Cell Co

All Key Metrics — Locus Cell Co